Optimisation of intellectual property can be critical to driving the competitive advantage of a business or start-up. We will help your business growth by protecting and leveraging your brand, ideas, inventions and innovations and your creative works.

With an enviable track-record in disputes, clients rely on our breadth and depth of knowledge to solve their most significant challenges across copyright, trade marks, designs and know-how. We have specific expertise in the therapeutic goods and general life sciences sector. We provide specialist advice to private and publicly listed companies, government entities and not-for-profit organisations including:

  • due diligence
  • collaborative development projects
  • brand protection
  • product labelling
  • divestment and acquisition of IP
  • advertising and promotions
  • new media and e-commerce
  • licensing of copyright, trade marks, patent protected inventions and know-how
  • protection and disclosure of confidential information
  • advice on copyright, trade marks, designs, circuit layouts and confidential information.

Experience

General

Australian Turf Club

Trusted advisors in relation to all key IP issues including representing ATC in IP Australia trade mark proceedings, drafting and negotiating musical performance agreements, talent agreements and sponsorship agreements and advising in relation to various media rights arrangements.

Bauer Media Pty Ltd

Defending copyright proceedings brought by the artist Vladas Meskenas, featuring the world's first litigated claim in relation to Moral Rights.

Fitness & Lifestyle Group

Providing IP advice and commencing opposition proceedings against Lorna Jane in relation to a trade mark application; advising on trade mark licensing agreement.

Flinders Port Holdings

Advised in relation to possible design infringement and misuse of confidential information claims.

Gensolve

Conducting chain of title investigation into proprietary Gensolve Practice Manager Software, as part of a restructure.

GoDaddy, Inc

Responding to allegations of IP infringement connected with websites hosted on GoDaddy registered domains.

JMI Equity

Advised on the Australian aspects of its acquisition of Serraview holdings, including a chain of title review of the target’s proprietary technologies.

Microsoft

Advising on IP risks and exposures in connection with projects ranging from proof of concept testing of AI bots to co-development of augmented reality simulations.

Osborne Clarke Germany

Providing advice on a confidential basis to one of their clients on copyright infringement and other risks associated with creating an interoperable software product to allow maintenance on the products of a third party manufacturer based in Australia.

Penten

Advising on the intellectual property commercialisation and protection strategy, including agreements relating to a jointly developed, co-marketed product with partner organisations.

Straxcorp

IP licensing and commercialisation arrangements in connection with a global collaboration for the creation of a cloud based software solution to be offered with a medical device to health practitioners and researchers.

Visioneering Technologies, Inc.

Advised on protection of IP, including action against an infringer.

Latest Insights

Committee report supports passage of Privacy Bill with amendments

This week marks a significant development in Australia’s privacy law reform process, which is likely to result in some changes becoming law before the next federal election.

More

Anti-competitive disparagement: think twice before you criticise your competitors’ products

The European Commission recently fined a large global pharmaceutical company €462.6 million for abusing its dominant position to lessen competition in the market for the supply of Copaxone...

More

Paying with scrip? Key considerations for junior ASX-listed mining companies

The past year has undoubtedly been challenging for companies in the lithium, rare earth and critical minerals sectors. To provide some context, lithium carbonate, lithium hydroxide and spodumene...

More

Do you need to disclose an ACCC investigation to comply with your continuous disclosure obligations?

Recent cases have highlighted whether an ASX-listed entity must make a market disclosure to the ASX if it receives a confidential compulsory investigation notice under section 155 of the...

More